Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6909126 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6914493 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8390458 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6907967 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6914515 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6913708 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6907695 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6908806 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL6914513 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3AKR1C1USP2ALDH1A1 | |
| SCHEMBL1605123 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4197374-A | FOAMS, FILMS, FIBERS, COATINGS, ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1980-04-08 | — | — | US | claimed |
| US-20240027902-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20230365558-A1 | TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230365558-A1 | TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-11720020-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11720020-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-4219461-A1 | TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF | Medshine Discovery Inc. (CN) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022063094-A1 | TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF | 南京明德新药研发有限公司 | 2022-03-31 | — | — | WO | disclosed |
| EP-3241822-B1 | URAT1 INHIBITOR | NIPPON CHEMIPHAR CO (JP) | 2021-03-24 | — | — | EP | disclosed |
| CN-107108478-B | URAT1 inhibitors | 日本化学药品株式会社 | 2020-04-24 | — | — | CN | disclosed |
| EP-0147053-A1 | A catalyst and a process for polymerization of olefins | Tonen Corporation (JP) | 1985-07-03 | — | — | EP | disclosed |
| EP-0145368-A2 | Process for producing propylene block copolymers | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-06-19 | — | — | EP | disclosed |
| EP-0141500-A1 | Catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-05-15 | — | — | EP | disclosed |
| EP-0140536-A1 | Catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-05-08 | — | — | EP | disclosed |
| EP-0136112-A2 | Catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0136113-A2 | Catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0044635-A1 | Catalyst components for polymerization of alpha-olefins and a method for using them | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1982-01-27 | — | — | EP | disclosed |
| US-4197374-A | FOAMS, FILMS, FIBERS, COATINGS, ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1980-04-08 | — | — | US | disclosed |
| US-4042571-A | Fire-retardant polyamides from naphthalene dicarboxylic reactant and halogenated carboxylic reactant | TEIJIN LIMITED (JA) | 1977-08-16 | — | — | US | disclosed |
| US-3954730-A | ANTIBIOTICS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365558-A1 | TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF | CYP3A7, UGT2B7, SFPQ | CYP2C19 50/4885FFAR3 1670/4885AKR1C1 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.